$1.32 Billion is the total value of Opti Capital Management, LP's 37 reported holdings in Q4 2021. The portfolio turnover from Q3 2021 to Q4 2021 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| Exit | CSG SYS INTL INCnote 4.250% 3/1 | $0 | – | -4,500,000 | -100.0% | -0.44% | – | |
| Exit | IRONWOOD PHARMACEUTICALS INCnote 0.750% 6/1 | $0 | – | -5,300,000 | -100.0% | -0.59% | – | |
| Exit | LIGAND PHARMACEUTICALS INCnote 0.750% 5/1 | $0 | – | -8,722,000 | -100.0% | -0.82% | – | |
| Exit | FLEXION THERAPEUTICS INCnote 3.375% 5/0 | $0 | – | -13,158,000 | -100.0% | -1.10% | – | |
| Exit | FIVE9 INCnote 0.500% 6/0 | $0 | – | -17,260,000 | -100.0% | -2.18% | – | |
| Exit | ON SEMICONDUCTOR CORPnote 1.625%10/1 | $0 | – | -25,411,000 | -100.0% | -5.37% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| SUPERNUS PHARMACEUTICALS INC | 14 | Q1 2023 | 6.9% |
| NEW RELIC INC | 14 | Q1 2023 | 7.6% |
| 8X8 INC NEW | 13 | Q3 2023 | 7.4% |
| MANDIANT INC | 12 | Q1 2022 | 9.9% |
| NUTANIX INC | 12 | Q4 2022 | 7.3% |
| OPKO HEALTH INC | 12 | Q3 2023 | 2.1% |
| INSIGHT ENTERPRISES INC | 10 | Q3 2023 | 5.6% |
| ALTERYX INC | 10 | Q3 2023 | 4.6% |
| IONIS PHARMACEUTICALS INC | 10 | Q1 2023 | 3.6% |
| MODEL N INC | 10 | Q3 2023 | 1.7% |
View Opti Capital Management, LP's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-15 |
View Opti Capital Management, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.